Palvella Therapeutics (PVLA) Revenue (QoQ) (2014 - 2024)
Palvella Therapeutics (PVLA) Revenue (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 101.89% |
| Dec 31, 2023 | -114.34% |
| Sep 30, 2023 | -2.67% |
| Jun 30, 2023 | 897.76% |
| Mar 31, 2023 | 1,367.15% |
| Dec 31, 2022 | -46.90% |
| Sep 30, 2022 | 12.17% |
| Jun 30, 2022 | -97.91% |
| Mar 31, 2022 | 30.14% |
| Dec 31, 2021 | 108.11% |
| Sep 30, 2021 | 444.56% |
| Jun 30, 2021 | -94.27% |
| Mar 31, 2021 | 467.75% |
| Dec 31, 2020 | -237.12% |
| Sep 30, 2020 | -76.41% |
| Jun 30, 2020 | -17.58% |
| Mar 31, 2020 | -23.21% |
| Dec 31, 2019 | 14.13% |
| Sep 30, 2019 | 183.80% |
| Jun 30, 2019 | -37.60% |